NASDAQ:KA

Kineta - KA Stock Forecast, Price & News

$3.01

-0.20 (-6.23%)

(As of 03/20/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.94
▼
$3.41
50-Day Range: $3.01
▼
$8.33
52-Week Range: $2.94
▼
$17.43

Volume: 67,825 shs
Average Volume: 22,597 shs
Market Capitalization: $4.67 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Headlines

SEC Filings

Social Media

About Kineta (NASDAQ:KA) Stock

Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.

Receive KA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter.

KA Stock News Headlines

March 8, 2023 | finance.yahoo.com

Kineta to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 6, 2023 | finance.yahoo.com

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA as an Immuno-Oncology Target

March 20, 2023 | Investing Daily (Ad)

How This Trader Banked A 97% Win Rate

Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself.

March 4, 2023 | ca.finance.yahoo.com

Kineta, Inc. (KA)

March 1, 2023 | finance.yahoo.com

Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory Board

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive KA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter.

KA Company Calendar

Today: 3/20/2023
Next Earnings (Estimated): 3/23/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:KA
CUSIP: N/A
CIK: 1445283
Web: www.kinetabio.com
Phone: (206) 378-0400
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($20.9937)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-39,500,000.00
Net Margins: -660.61%
Pretax Margin: -660.61%
Return on Equity: -263.34%
Return on Assets: -107.08%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.21
Quick Ratio: 2.21

Sales & Book Value

Annual Sales: $8.04 million
Price / Sales: 0.58
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $15.95 per share
Price / Book: 0.19

Miscellaneous

Outstanding Shares: 1,550,000
Free Float: 1,360,000
Market Cap: $4.67 million
Optionable: Not Optionable
Beta: 0.49

Key Executives

Shawn P. Iadonato
Chief Executive Officer & Director

Craig W. Philips
President

Keith Baker
Chief Financial Officer

Thierry Guillaudeux
Chief Scientific Officer

Jacques Bouchy
EVP-Investor Relations & Business Development

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

KA Stock - Frequently Asked Questions

How have KA shares performed in 2023?: Kineta's stock was trading at $6.35 at the beginning of 2023. Since then, KA stock has decreased by 52.6% and is now trading at $3.01.
View the best growth stocks for 2023 here.
When is Kineta's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our KA earnings forecast.
What is Kineta's stock symbol?: Kineta trades on the NASDAQ under the ticker symbol "KA."
Who are Kineta's major shareholders?: Kineta's stock is owned by many different institutional and retail investors. Top institutional investors include Artal Group S.A. (2.00%) and Renaissance Technologies LLC (1.13%).

How do I buy shares of Kineta?: Shares of KA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Kineta's stock price today?: One share of KA stock can currently be purchased for approximately $3.01.
How much money does Kineta make?: Kineta (NASDAQ:KA) has a market capitalization of $4.67 million and generates $8.04 million in revenue each year. The company earns $-39,500,000.00 in net income (profit) each year or ($20.9937) on an earnings per share basis.
How can I contact Kineta?: Kineta's mailing address is 40 GUEST STREET SUITE 4410, BOSTON MA, 02135. The official website for the company is www.kinetabio.com. The company can be reached via phone at (206) 378-0400 or via email at lroth@burnsmc.com.

This page (NASDAQ:KA) was last updated on 3/20/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Kineta - KA Stock Forecast, Price & News

About Kineta (NASDAQ:KA) Stock

KA Stock News Headlines

KA Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

KA Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info